ES476109A1 - Procedimiento para la preparacion de derivados de cefalospo-rina - Google Patents

Procedimiento para la preparacion de derivados de cefalospo-rina

Info

Publication number
ES476109A1
ES476109A1 ES476109A ES476109A ES476109A1 ES 476109 A1 ES476109 A1 ES 476109A1 ES 476109 A ES476109 A ES 476109A ES 476109 A ES476109 A ES 476109A ES 476109 A1 ES476109 A1 ES 476109A1
Authority
ES
Spain
Prior art keywords
optionally substituted
see image
preparation
general formula
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES476109A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES476109A1 publication Critical patent/ES476109A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES476109A 1977-12-24 1978-12-19 Procedimiento para la preparacion de derivados de cefalospo-rina Expired ES476109A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772758001 DE2758001A1 (de) 1977-12-24 1977-12-24 Cephalosporinderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ES476109A1 true ES476109A1 (es) 1979-10-16

Family

ID=6027279

Family Applications (1)

Application Number Title Priority Date Filing Date
ES476109A Expired ES476109A1 (es) 1977-12-24 1978-12-19 Procedimiento para la preparacion de derivados de cefalospo-rina

Country Status (20)

Country Link
US (1) US4293550A (enExample)
EP (1) EP0002765B1 (enExample)
JP (1) JPS5495592A (enExample)
AT (1) AT365599B (enExample)
AU (1) AU534258B2 (enExample)
CA (1) CA1109461A (enExample)
DE (2) DE2758001A1 (enExample)
DK (1) DK578978A (enExample)
EG (1) EG13762A (enExample)
ES (1) ES476109A1 (enExample)
FI (1) FI66007C (enExample)
GR (1) GR65234B (enExample)
HU (1) HU184140B (enExample)
IE (1) IE48147B1 (enExample)
IL (1) IL56284A (enExample)
NO (1) NO784366L (enExample)
NZ (1) NZ189266A (enExample)
PH (1) PH15925A (enExample)
PT (1) PT68964A (enExample)
ZA (1) ZA787209B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4703046A (en) * 1978-09-08 1987-10-27 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds and processes for preparation thereof
BE885487A (fr) * 1979-10-02 1981-04-01 Glaxo Group Ltd Nouvelles cephalosporines et leur preparation
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
DE3006888A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
JPS57131794A (en) * 1980-12-31 1982-08-14 Fujisawa Pharmaceut Co Ltd Novel cephem compound or salt thereof, preparation of the same and preventing agent and remedy for microbism containing the same as active constituent
US4427677A (en) * 1980-12-31 1984-01-24 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
DE3177090D1 (en) * 1980-12-31 1989-09-28 Fujisawa Pharmaceutical Co 7-acylaminocephalosporanic acid derivatives and processes for the preparation thereof
US4618606A (en) * 1982-11-17 1986-10-21 Toyama Chemical Co., Ltd. Antibiotic 7-(thiazolyl)-3-(pyrazinylmethyl) or (pyridazinylmethyl) cephalosporins
EP1059293A1 (en) * 1995-10-12 2000-12-13 Microcide Pharmaceuticals, Inc. Novel amino chlorothiazole compounds
IT1295935B1 (it) * 1997-10-30 1999-05-28 Acs Dobfar Spa Derivati aminotiazolici utili nella preparazione di antibiotici b -lattamici
TWI335332B (en) * 2001-10-12 2011-01-01 Theravance Inc Cross-linked vancomycin-cephalosporin antibiotics
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
KR20130112848A (ko) 2010-06-02 2013-10-14 아레나 파마슈티칼스, 인크. 5-ｈｔ2ｃ 수용체 아고니스트의 제조 방법
WO2012030957A2 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-ht2c agonists
JP2013540719A (ja) 2010-09-01 2013-11-07 アリーナ ファーマシューティカルズ， インコーポレイテッド 腎欠陥を有する個体へのロルカセリンの投与
CA2808912C (en) 2010-09-01 2019-09-17 Zezhi Jesse Shao Modified-release dosage forms of 5-ht2c agonists useful for weight management
KR20130138770A (ko) 2010-09-01 2013-12-19 아레나 파마슈티칼스, 인크. 광학적으로 활성 산을 갖는 로르카세린의 염
KR20190128001A (ko) 2012-10-09 2019-11-13 에자이 알앤드디 매니지먼트 가부시키가이샤 체중 관리 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5168589A (enExample) * 1974-12-06 1976-06-14 Shionogi Seiyaku Kk
DK154939C (da) 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
GB1536281A (en) * 1975-06-09 1978-12-20 Takeda Chemical Industries Ltd Cephem compounds
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
ATA924178A (de) 1981-06-15
GR65234B (en) 1980-07-30
IE48147B1 (en) 1984-10-17
EG13762A (en) 1982-09-30
NO784366L (no) 1979-06-26
EP0002765A1 (de) 1979-07-11
FI66007C (fi) 1984-08-10
IL56284A0 (en) 1979-03-12
FI783960A7 (fi) 1979-06-25
PT68964A (de) 1979-01-01
AT365599B (de) 1982-01-25
NZ189266A (en) 1981-12-15
IE782546L (en) 1979-06-24
IL56284A (en) 1983-03-31
DE2758001A1 (de) 1979-07-12
AU4284878A (en) 1979-06-28
DK578978A (da) 1979-06-25
JPH0132226B2 (enExample) 1989-06-29
CA1109461A (en) 1981-09-22
JPS5495592A (en) 1979-07-28
EP0002765B1 (de) 1981-09-02
DE2861043D1 (en) 1981-11-26
PH15925A (en) 1983-04-26
ZA787209B (en) 1979-12-27
FI66007B (fi) 1984-04-30
AU534258B2 (en) 1984-01-12
US4293550A (en) 1981-10-06
HU184140B (en) 1984-07-30

Similar Documents

Publication Publication Date Title
ES476109A1 (es) Procedimiento para la preparacion de derivados de cefalospo-rina
DK151009C (da) Analogifremgangsmaade til fremstilling af benzhydrylsulfinylforbindelser og fysiologisk acceptable syreadditionssalte deraf
DK295183A (da) Fremgangsmaade til fremstilling af benzoesyrepiperidylesterderivater
ES491224A0 (es) Procedimiento para la preparacion de anilidas de acidos 4- amino-2-ureido-(o-tioureido)-pirimidin-5-carboxilicos
SE7600012L (sv) Bensoesyror och deras derivat samt forfarande for deras framstellning.
DK128380A (da) 4-amino-3-quinolin-carboxylsyrer og syreestere deres fremstilling og anvendelse
BG35189A3 (en) Method for preparing derivatives of 6- beta- hydroxyalkylpenicillanic acid
SE7902910L (sv) 4-tiazolidinkarboxylsyror
FR2336126A1 (fr) Derives d'esters d'acide phenylacetique
JPS57108073A (en) N-substituted omega-(2-oxo-4-imidazoline- 1-yl)alkanoic acid compound
BG32269A3 (bg) Метод за получаване на производни на тиазолидин-(тиазан)-карбонови киселини
DK294180A (da) Hidtil ukendte carboxylsyrederivater deres fremstilling og anvendelse
NZ187812A (en) Imidazolinyl benzoic acid derivatives and herbicidal compositions
GR3006489T3 (enExample)
NZ191524A (en) Aminoacylthio alkanoic acid heterocyclic amide derivatives and pharmacuetical compositions
NZ193107A (en) 1-hydroxy-2-piperazinylethyl derivatives of benzoic acid pharmaceutical compositions
NO874109L (no) Salicylsyreamider, fremgangsmaate til deres fremstilling og deres anvendelse.
NZ194241A (en) 7b-aminothiadiazolylacetamido-3-cephem-4 carboxylic acid derivatives and pharmaceutical compositions
DK525478A (da) (%n-dialkyl-o-pyrimidinyl-carbaminsyreestere deres fremstilling og deres anvendelse som insecticider
BG30772A3 (bg) Метод за получаване на естери на 3-метил-2(2-хлорсулфинил-4-оксо-3- феноксиацетамидо-1-азетидинил)-3-бутенова киселина
ZA834767B (en) Benzoic acid piperidyl ester derivatives
BG34454A3 (bg) Метод за получаване на производни на 7 бета- аминотиазолилацетамидо- 3- цефем- 4- карбоновата киселина
ATE73812T1 (de) Thionophosphonsaeureester.
BG30928A3 (en) Method for obtaining of 2- /3- aryl- 5- isoxazolin benzoic acids
DK343481A (da) Substitueret ureidobenzylpenicillansyre og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971001